BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 23743325)

  • 1. Tumor growth suppression by gadolinium-neutron capture therapy using gadolinium-entrapped liposome as gadolinium delivery agent.
    Dewi N; Yanagie H; Zhu H; Demachi K; Shinohara A; Yokoyama K; Sekino M; Sakurai Y; Morishita Y; Iyomoto N; Nagasaki T; Horiguchi Y; Nagasaki Y; Nakajima J; Ono M; Kakimi K; Takahashi H
    Biomed Pharmacother; 2013 Jul; 67(6):451-7. PubMed ID: 23743325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo evaluation of neutron capture therapy effectivity using calcium phosphate-based nanoparticles as Gd-DTPA delivery agent.
    Dewi N; Mi P; Yanagie H; Sakurai Y; Morishita Y; Yanagawa M; Nakagawa T; Shinohara A; Matsukawa T; Yokoyama K; Cabral H; Suzuki M; Sakurai Y; Tanaka H; Ono K; Nishiyama N; Kataoka K; Takahashi H
    J Cancer Res Clin Oncol; 2016 Apr; 142(4):767-75. PubMed ID: 26650198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into the use of gadolinium and gadolinium/boron-based agents in imaging-guided neutron capture therapy applications.
    Deagostino A; Protti N; Alberti D; Boggio P; Bortolussi S; Altieri S; Crich SG
    Future Med Chem; 2016 May; 8(8):899-917. PubMed ID: 27195428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo evaluation of PEGylated-liposome encapsulating gadolinium complexes for gadolinium neutron capture therapy.
    Lee W; Jung KH; Park JA; Kim JY; Lee YJ; Chang Y; Yoo J
    Biochem Biophys Res Commun; 2021 Sep; 568():23-29. PubMed ID: 34174538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a Gadolinium-Boron-Conjugated Albumin for MRI-Guided Neutron Capture Therapy.
    Okada S; Nishimura K; Ainaya Q; Shiraishi K; Anufriev SA; Sivaev IB; Sakurai Y; Suzuki M; Yokoyama M; Nakamura H
    Mol Pharm; 2023 Dec; 20(12):6311-6318. PubMed ID: 37909734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo evaluation of the effects of combined boron and gadolinium neutron capture therapy in mouse models.
    Lee W; Kim KW; Lim JE; Sarkar S; Kim JY; Chang Y; Yoo J
    Sci Rep; 2022 Aug; 12(1):13360. PubMed ID: 35922534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-circulating gadolinium-encapsulated liposomes for potential application in tumor neutron capture therapy.
    Le UM; Cui Z
    Int J Pharm; 2006 Apr; 312(1-2):105-12. PubMed ID: 16457973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of boron and gadolinium compounds for neutron capture therapy. An in vitro study.
    Matsumura A; Zhang T; Nakai K; Endo K; Kumada H; Yamamoto T; Yoshida F; Sakurai Y; Yamamoto K; Nose T
    J Exp Clin Cancer Res; 2005 Mar; 24(1):93-8. PubMed ID: 15943038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI-guided neutron capture therapy by use of a dual gadolinium/boron agent targeted at tumour cells through upregulated low-density lipoprotein transporters.
    Geninatti-Crich S; Alberti D; Szabo I; Deagostino A; Toppino A; Barge A; Ballarini F; Bortolussi S; Bruschi P; Protti N; Stella S; Altieri S; Venturello P; Aime S
    Chemistry; 2011 Jul; 17(30):8479-86. PubMed ID: 21671294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular uptake and in vitro antitumor efficacy of composite liposomes for neutron capture therapy.
    Peters T; Grunewald C; Blaickner M; Ziegner M; Schütz C; Iffland D; Hampel G; Nawroth T; Langguth P
    Radiat Oncol; 2015 Feb; 10():52. PubMed ID: 25889824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A theranostic approach based on the use of a dual boron/Gd agent to improve the efficacy of Boron Neutron Capture Therapy in the lung cancer treatment.
    Alberti D; Protti N; Toppino A; Deagostino A; Lanzardo S; Bortolussi S; Altieri S; Voena C; Chiarle R; Geninatti Crich S; Aime S
    Nanomedicine; 2015 Apr; 11(3):741-50. PubMed ID: 25596074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biodistribution and tumor-accumulation of gadolinium (Gd) encapsulated in long-circulating liposomes in tumor-bearing mice for potential neutron capture therapy.
    Le UM; Cui Z
    Int J Pharm; 2006 Aug; 320(1-2):96-103. PubMed ID: 16713149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gadolinium neutron capture therapy (GdNCT) of melanoma cells and solid tumors with the magnetic resonance imaging contrast agent Gadobutrol.
    Hofmann B; Fischer CO; Lawaczeck R; Platzek J; Semmler W
    Invest Radiol; 1999 Feb; 34(2):126-33. PubMed ID: 9951792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A thermo-sensitive polymeric gel containing a gadolinium (Gd) compound encapsulated into liposomes significantly extended the retention of the Gd in tumors.
    Le UM; Shaker DS; Sloat BR; Cui Z
    Drug Dev Ind Pharm; 2008 Apr; 34(4):413-8. PubMed ID: 18401783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gadolinium neutron-capture therapy using novel gadopentetic acid-chitosan complex nanoparticles: in vivo growth suppression of experimental melanoma solid tumor.
    Tokumitsu H; Hiratsuka J; Sakurai Y; Kobayashi T; Ichikawa H; Fukumori Y
    Cancer Lett; 2000 Mar; 150(2):177-82. PubMed ID: 10704740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Image-Guided Neutron Capture Therapy Using the Gd-DO3A-BTA Complex as a New Combinatorial Treatment Approach.
    Jung KH; Park JA; Kim JY; Kim MH; Oh S; Kim HK; Choi EJ; Kim HJ; Do SH; Lee KC; Kim KM; Lee YJ; Chang Y
    Contrast Media Mol Imaging; 2018; 2018():3727109. PubMed ID: 30515066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PEGylated liposome encapsulating nido-carborane showed significant tumor suppression in boron neutron capture therapy (BNCT).
    Lee W; Sarkar S; Ahn H; Kim JY; Lee YJ; Chang Y; Yoo J
    Biochem Biophys Res Commun; 2020 Feb; 522(3):669-675. PubMed ID: 31787237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accumulation of boron compounds to tumor with polyethylene-glycol binding liposome by using neutron capture autoradiography.
    Yanagië H; Ogura K; Takagi K; Maruyama K; Matsumoto T; Sakurai Y; Skvarc J; Illic R; Kuhne G; Hisa T; Yoshizaki I; Kono K; Furuya Y; Sugiyama H; Kobayashi H; Ono K; Nakagawa K; Eriguchi M
    Appl Radiat Isot; 2004 Oct; 61(4):639-46. PubMed ID: 15246411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dodecaborate lipid liposomes as new vehicles for boron delivery system of neutron capture therapy.
    Ueno M; Ban HS; Nakai K; Inomata R; Kaneda Y; Matsumura A; Nakamura H
    Bioorg Med Chem; 2010 May; 18(9):3059-65. PubMed ID: 20371186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of boron-entrapped stealth liposomes to inhibition of growth of tumour cells in the in vivo boron neutron-capture therapy model.
    Yanagie H; Maruyama K; Takizawa T; Ishida O; Ogura K; Matsumoto T; Sakurai Y; Kobayashi T; Shinohara A; Rant J; Skvarc J; Ilic R; Kuhne G; Chiba M; Furuya Y; Sugiyama H; Hisa T; Ono K; Kobayashi H; Eriguchi M
    Biomed Pharmacother; 2006 Jan; 60(1):43-50. PubMed ID: 16260113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.